Press releases

29
Apr 2020
20:30 E.S.T.

Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT

Read more
13
Apr 2020
20:30 E.S.T.

Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer

Read more
10
Mar 2020
20:30 E.S.T.

US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis

Read more
4
Mar 2020
21:30 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

Read more
4
Mar 2020
21:05 E.S.T.

Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products

Read more
25
Feb 2020
21:30 E.S.T.

Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST

Read more
18
Feb 2020
21:30 E.S.T.

Cellectis and Servier Expand Collaboration on UCART19 Products

Read more
15
Jan 2020
21:30 E.S.T.

First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia

Read more
12
Jan 2020
21:00 E.S.T.

Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement

Read more
6
Jan 2020
21:30 E.S.T.

An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug Discovery

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US